Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.64% | 25.06% | 44.19% | 23.13% | -38.03% |
| Total Depreciation and Amortization | 159.14% | 168.66% | 56.84% | -69.02% | -68.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.74% | 5.70% | -47.62% | -5.65% | 691.45% |
| Change in Net Operating Assets | -84.02% | -126.08% | -89.50% | 545.62% | 397.46% |
| Cash from Operations | 1.34% | -0.10% | 32.28% | 100.33% | 60.69% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 2,303.67% | 389.08% | -- | -- |
| Total Debt Repaid | 76.18% | -- | -- | -1.86% | 43.45% |
| Issuance of Common Stock | -- | -- | -- | -98.05% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 27.30% | 18.93% | -17.37% | -101.34% | -63.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 413.48% | -52.65% | 204.55% | -255.26% | 15.75% |